Research Article iMedPub Journals 2017 www.imedpub.com Womens Health and Reproductive Medicine Vol.1 No.1:6 Prophylactic Oxytocin before Versus Amr AA Nadim, after Placental Delivery to Reduce Amr H Yehia and Reham Marie Farghal* Blood Loss in Vaginal Delivery: A Randomized Controlled Trial Department of Obstetrics and Gynecology, Ain Shams University, Egypt *Corresponding author: Abstract Reham Marie Farghal Background: PPH has been a leading cause of maternal death around the globe. Prophylactic oxytocin is one of the main components of the active management
[email protected] of the third stage of labor to reduce blood loss. The timing of administration of prophylactic oxytocin varies considerably worldwide and it may have significant Department of Obstetrics and Gynecology, impact on the maternal and neonatal well-being. Ain Shams University, Egypt. Objectives: To assess the efficacy and safety of the timing of administration of prophylactic oxytocin via intramuscular route (before compared to after placental Tel: +20226831474 delivery) on blood loss in vaginal delivery. Methods: It is a double blinded study in which 403 patients were randomized in two groups to receive oxytocin 10 IU IM either before or after placental delivery. Citation: Nadim AAA, Yehia AH, Farghal RM Primiparous patients, patients with high risk for PPH and those with multiple (2017) Prophylactic Oxytocin before Versus vaginal or cervical tears were excluded from the study. All patients underwent after Placental Delivery to Reduce Blood controlled cord traction, immediate cord clamping. Results: Our results have Loss in Vaginal Delivery: A Randomized shown that there were no statistically significant differences between the two Controlled Trial.